Search filters

List of works by Julie A. McEarchern

Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis

scientific article published on 26 August 2009

CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.

scientific article published on 23 January 2008

Clinical binding properties, internalization kinetics, and clinicopathologic activity of brentuximab vedotin: an antibody-drug conjugate for CD30-positive lymphoid neoplasms

scientific article published on 26 April 2012

Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma

scientific article

Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses

scientific article published on 15 February 2003

Distinct apoptotic signaling characteristics of the anti-CD40 monoclonal antibody dacetuzumab and rituximab produce enhanced antitumor activity in non-Hodgkin lymphoma

scientific article published on 24 May 2011

Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities

scientific article published on 12 October 2006

Immunosuppressive factors in the tumor environment: Potential implications for immune-based therapies

scientific article published on 01 February 2001

Interferon gamma and antisense transforming growth factor beta transgenes synergize to enhance the immunogenicity of a murine mammary carcinoma

scientific article published on 01 May 1999

Invasion and metastasis of a mammary tumor involves TGF-beta signaling

scientific article

Novel antibody-based therapeutic agents targeting CD70: a potential approach for treating Waldenström's macroglobulinemia

scientific article published on March 2009

Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.

scientific article published on September 2005

Preclinical characterization of SGN-70, a humanized antibody directed against CD70

scientific article published on 01 December 2008

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.

scientific article published on 14 June 2013

Targeting CD70 for human therapeutic use.

scientific article published on January 2009

Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75

scientific article published on July 27, 2010